ANNX

STO · Equity

Annexin Pharmaceuticals AB (publ)

SE Healthcare Biotechnology

Latest week
29 May 2026
Close
13.550000
Fair value
34.361611
Expectation
Negative 44.25%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
13.55
12-Week Change
-7.82%
Trend Signal
Inactive
Expectation
Negative 44.25%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-46.05
Market Dynamics
0.44

Over the latest 12 completed weeks ending 2026-05-29, ANNX fell 7.82%, moving from 14.70 to 13.55. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -46.05 and has improved across the 12-week window. Market Dynamics is 0.44 on the latest week. Expectation is negative at 44.25%.